000 | 01168cam a2200301 4500 | ||
---|---|---|---|
001 | 9243204033 | ||
020 | _a9243204033 | ||
035 | _a(Sirsi) 9243204033 | ||
060 | _aQV 771 | ||
110 | 2 | _aWHO Scientific Group on Principles for the Clinical Evaluation of Drugs. | |
245 | 0 | 0 |
_aPrincipios aplicables a la evaluaci'on cl'inica de los medicamentos : _binforme de un Grupo Cient'ifico de la OMS [se reuni'o en Ginebra del 13 al 18 de noviembre de 1967] |
260 |
_aGinebra : _bOrganizaci'on Mundial de la Salud, _c1968. |
||
300 | _a34 p. | ||
440 | 0 |
_aOrganizaci'on Mundial de la Salud. _pSerie de informes técnicos ; _vno. 403 |
|
501 | _aCopy 2 of English, French and Spanish eds. bound together. | ||
535 | _aCopy 2 shelved under QV771 68WH (English title) | ||
546 | _aeng fre por rus spa. | ||
546 | _aita jpn. | ||
561 | _aWHO monograph | ||
596 | _a4 | ||
650 | 0 | 2 |
_aPharmaceutical preparations _xadverse effects. |
650 | 0 | 2 | _aDrug evaluation. |
650 | 0 | 2 | _aClinical trials. |
710 | 2 | _aWorld Health Organization. | |
856 | _uhttps://apps.who.int/iris/ | ||
008 | s1968 0 spa | ||
942 |
_2NLM _cMONOGRAPH |
||
999 |
_c11001 _d11001 |